GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: NBRV
Outperform $21

Nabriva Therapeutics (NBRV) rated to Outperform with price target $21 by RBC Capital Mkts

Tuesday,  Oct 13, 2015  8:25 AM ET by Lynn Gilbert

RBC Capital Mkts rated
Nabriva Therapeutics (NBRV) to Outperform with price target $21.



RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy